nodes	percent_of_prediction	percent_of_DWPC	metapath
Ibandronate—FDPS—respiratory system—lung cancer	0.00578	0.211	CbGeAlD
Ibandronate—FDPS—bronchus—lung cancer	0.00475	0.174	CbGeAlD
Ibandronate—FDPS—trachea—lung cancer	0.00427	0.156	CbGeAlD
Ibandronate—FDPS—cardiac atrium—lung cancer	0.00401	0.147	CbGeAlD
Ibandronate—FDPS—bone marrow—lung cancer	0.00338	0.124	CbGeAlD
Ibandronate—FDPS—lung—lung cancer	0.00307	0.112	CbGeAlD
Ibandronate—FDPS—lymph node—lung cancer	0.0021	0.0767	CbGeAlD
Ibandronate—Risedronate—PTGS2—lung cancer	0.000819	1	CrCbGaD
Ibandronate—Gastritis—Doxorubicin—lung cancer	0.000429	0.000441	CcSEcCtD
Ibandronate—Pain—Cisplatin—lung cancer	0.000429	0.000441	CcSEcCtD
Ibandronate—Vomiting—Vinorelbine—lung cancer	0.000426	0.000438	CcSEcCtD
Ibandronate—Body temperature increased—Gemcitabine—lung cancer	0.000425	0.000437	CcSEcCtD
Ibandronate—Renal failure—Methotrexate—lung cancer	0.000424	0.000436	CcSEcCtD
Ibandronate—Rash—Vinorelbine—lung cancer	0.000422	0.000434	CcSEcCtD
Ibandronate—Dermatitis—Vinorelbine—lung cancer	0.000422	0.000434	CcSEcCtD
Ibandronate—Stomatitis—Methotrexate—lung cancer	0.00042	0.000433	CcSEcCtD
Ibandronate—Headache—Vinorelbine—lung cancer	0.000419	0.000432	CcSEcCtD
Ibandronate—Dysphagia—Doxorubicin—lung cancer	0.000419	0.000431	CcSEcCtD
Ibandronate—Asthma—Doxorubicin—lung cancer	0.000419	0.000431	CcSEcCtD
Ibandronate—Influenza—Doxorubicin—lung cancer	0.000419	0.000431	CcSEcCtD
Ibandronate—Sweating—Methotrexate—lung cancer	0.000413	0.000425	CcSEcCtD
Ibandronate—Palpitations—Docetaxel—lung cancer	0.000413	0.000425	CcSEcCtD
Ibandronate—Feeling abnormal—Cisplatin—lung cancer	0.000413	0.000425	CcSEcCtD
Ibandronate—Paraesthesia—Etoposide—lung cancer	0.000412	0.000424	CcSEcCtD
Ibandronate—Musculoskeletal discomfort—Paclitaxel—lung cancer	0.00041	0.000422	CcSEcCtD
Ibandronate—Hepatobiliary disease—Methotrexate—lung cancer	0.000408	0.00042	CcSEcCtD
Ibandronate—Insomnia—Paclitaxel—lung cancer	0.000407	0.000419	CcSEcCtD
Ibandronate—Hypersensitivity—Irinotecan—lung cancer	0.000407	0.000419	CcSEcCtD
Ibandronate—Paraesthesia—Paclitaxel—lung cancer	0.000404	0.000416	CcSEcCtD
Ibandronate—Hypertension—Docetaxel—lung cancer	0.000404	0.000415	CcSEcCtD
Ibandronate—Bronchitis—Doxorubicin—lung cancer	0.000403	0.000415	CcSEcCtD
Ibandronate—Decreased appetite—Etoposide—lung cancer	0.000399	0.000411	CcSEcCtD
Ibandronate—Chest pain—Docetaxel—lung cancer	0.000398	0.00041	CcSEcCtD
Ibandronate—Arthralgia—Docetaxel—lung cancer	0.000398	0.00041	CcSEcCtD
Ibandronate—Myalgia—Docetaxel—lung cancer	0.000398	0.00041	CcSEcCtD
Ibandronate—Nausea—Vinorelbine—lung cancer	0.000398	0.000409	CcSEcCtD
Ibandronate—Gastrointestinal disorder—Etoposide—lung cancer	0.000396	0.000408	CcSEcCtD
Ibandronate—Dyspepsia—Paclitaxel—lung cancer	0.000396	0.000408	CcSEcCtD
Ibandronate—Body temperature increased—Cisplatin—lung cancer	0.000396	0.000408	CcSEcCtD
Ibandronate—Asthenia—Irinotecan—lung cancer	0.000396	0.000408	CcSEcCtD
Ibandronate—Fatigue—Etoposide—lung cancer	0.000396	0.000407	CcSEcCtD
Ibandronate—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	0.000395	0.000407	CcSEcCtD
Ibandronate—Constipation—Etoposide—lung cancer	0.000393	0.000404	CcSEcCtD
Ibandronate—Pain—Etoposide—lung cancer	0.000393	0.000404	CcSEcCtD
Ibandronate—Decreased appetite—Paclitaxel—lung cancer	0.000391	0.000403	CcSEcCtD
Ibandronate—Dry mouth—Docetaxel—lung cancer	0.000389	0.000401	CcSEcCtD
Ibandronate—Upper respiratory tract infection—Doxorubicin—lung cancer	0.000389	0.000401	CcSEcCtD
Ibandronate—Haemoglobin—Methotrexate—lung cancer	0.000389	0.0004	CcSEcCtD
Ibandronate—Gastrointestinal disorder—Paclitaxel—lung cancer	0.000389	0.0004	CcSEcCtD
Ibandronate—Fatigue—Paclitaxel—lung cancer	0.000388	0.000399	CcSEcCtD
Ibandronate—Haemorrhage—Methotrexate—lung cancer	0.000387	0.000398	CcSEcCtD
Ibandronate—Asthenia—Gemcitabine—lung cancer	0.000386	0.000397	CcSEcCtD
Ibandronate—Pain—Paclitaxel—lung cancer	0.000385	0.000396	CcSEcCtD
Ibandronate—Constipation—Paclitaxel—lung cancer	0.000385	0.000396	CcSEcCtD
Ibandronate—Pharyngitis—Methotrexate—lung cancer	0.000384	0.000395	CcSEcCtD
Ibandronate—Urinary tract disorder—Methotrexate—lung cancer	0.000382	0.000393	CcSEcCtD
Ibandronate—Anaphylactic shock—Docetaxel—lung cancer	0.000382	0.000393	CcSEcCtD
Ibandronate—Pruritus—Gemcitabine—lung cancer	0.000381	0.000392	CcSEcCtD
Ibandronate—Urethral disorder—Methotrexate—lung cancer	0.00038	0.000391	CcSEcCtD
Ibandronate—Infection—Docetaxel—lung cancer	0.000379	0.00039	CcSEcCtD
Ibandronate—Weight decreased—Doxorubicin—lung cancer	0.000379	0.00039	CcSEcCtD
Ibandronate—Feeling abnormal—Etoposide—lung cancer	0.000378	0.000389	CcSEcCtD
Ibandronate—Diarrhoea—Irinotecan—lung cancer	0.000378	0.000389	CcSEcCtD
Ibandronate—Pneumonia—Doxorubicin—lung cancer	0.000376	0.000387	CcSEcCtD
Ibandronate—Gastrointestinal pain—Etoposide—lung cancer	0.000376	0.000386	CcSEcCtD
Ibandronate—Shock—Docetaxel—lung cancer	0.000375	0.000386	CcSEcCtD
Ibandronate—Nervous system disorder—Docetaxel—lung cancer	0.000374	0.000385	CcSEcCtD
Ibandronate—Infestation NOS—Doxorubicin—lung cancer	0.000373	0.000384	CcSEcCtD
Ibandronate—Infestation—Doxorubicin—lung cancer	0.000373	0.000384	CcSEcCtD
Ibandronate—Feeling abnormal—Paclitaxel—lung cancer	0.000371	0.000382	CcSEcCtD
Ibandronate—Skin disorder—Docetaxel—lung cancer	0.000371	0.000381	CcSEcCtD
Ibandronate—Hypersensitivity—Cisplatin—lung cancer	0.000369	0.00038	CcSEcCtD
Ibandronate—Gastrointestinal pain—Paclitaxel—lung cancer	0.000368	0.000379	CcSEcCtD
Ibandronate—Diarrhoea—Gemcitabine—lung cancer	0.000368	0.000379	CcSEcCtD
Ibandronate—Renal failure—Doxorubicin—lung cancer	0.000367	0.000378	CcSEcCtD
Ibandronate—Dizziness—Irinotecan—lung cancer	0.000365	0.000376	CcSEcCtD
Ibandronate—Urticaria—Etoposide—lung cancer	0.000365	0.000375	CcSEcCtD
Ibandronate—Stomatitis—Doxorubicin—lung cancer	0.000364	0.000375	CcSEcCtD
Ibandronate—Abdominal pain—Etoposide—lung cancer	0.000363	0.000374	CcSEcCtD
Ibandronate—Body temperature increased—Etoposide—lung cancer	0.000363	0.000374	CcSEcCtD
Ibandronate—Urinary tract infection—Doxorubicin—lung cancer	0.000363	0.000374	CcSEcCtD
Ibandronate—Eye disorder—Methotrexate—lung cancer	0.000362	0.000372	CcSEcCtD
Ibandronate—Asthenia—Cisplatin—lung cancer	0.00036	0.00037	CcSEcCtD
Ibandronate—Cardiac disorder—Methotrexate—lung cancer	0.000359	0.00037	CcSEcCtD
Ibandronate—Sweating—Doxorubicin—lung cancer	0.000358	0.000368	CcSEcCtD
Ibandronate—Urticaria—Paclitaxel—lung cancer	0.000358	0.000368	CcSEcCtD
Ibandronate—Abdominal pain—Paclitaxel—lung cancer	0.000356	0.000366	CcSEcCtD
Ibandronate—Body temperature increased—Paclitaxel—lung cancer	0.000356	0.000366	CcSEcCtD
Ibandronate—Hepatobiliary disease—Doxorubicin—lung cancer	0.000353	0.000363	CcSEcCtD
Ibandronate—Angiopathy—Methotrexate—lung cancer	0.000351	0.000361	CcSEcCtD
Ibandronate—Vomiting—Irinotecan—lung cancer	0.000351	0.000361	CcSEcCtD
Ibandronate—Immune system disorder—Methotrexate—lung cancer	0.00035	0.00036	CcSEcCtD
Ibandronate—Mediastinal disorder—Methotrexate—lung cancer	0.000349	0.000359	CcSEcCtD
Ibandronate—Rash—Irinotecan—lung cancer	0.000348	0.000358	CcSEcCtD
Ibandronate—Dermatitis—Irinotecan—lung cancer	0.000348	0.000358	CcSEcCtD
Ibandronate—Musculoskeletal discomfort—Docetaxel—lung cancer	0.000348	0.000358	CcSEcCtD
Ibandronate—Chills—Methotrexate—lung cancer	0.000347	0.000357	CcSEcCtD
Ibandronate—Headache—Irinotecan—lung cancer	0.000346	0.000356	CcSEcCtD
Ibandronate—Insomnia—Docetaxel—lung cancer	0.000345	0.000355	CcSEcCtD
Ibandronate—Diarrhoea—Cisplatin—lung cancer	0.000343	0.000353	CcSEcCtD
Ibandronate—Paraesthesia—Docetaxel—lung cancer	0.000343	0.000353	CcSEcCtD
Ibandronate—Alopecia—Methotrexate—lung cancer	0.000342	0.000352	CcSEcCtD
Ibandronate—Vomiting—Gemcitabine—lung cancer	0.000342	0.000352	CcSEcCtD
Ibandronate—Mental disorder—Methotrexate—lung cancer	0.000339	0.000349	CcSEcCtD
Ibandronate—Rash—Gemcitabine—lung cancer	0.000339	0.000349	CcSEcCtD
Ibandronate—Dermatitis—Gemcitabine—lung cancer	0.000339	0.000349	CcSEcCtD
Ibandronate—Hypersensitivity—Etoposide—lung cancer	0.000338	0.000348	CcSEcCtD
Ibandronate—Erythema—Methotrexate—lung cancer	0.000337	0.000347	CcSEcCtD
Ibandronate—Malnutrition—Methotrexate—lung cancer	0.000337	0.000347	CcSEcCtD
Ibandronate—Haemoglobin—Doxorubicin—lung cancer	0.000337	0.000347	CcSEcCtD
Ibandronate—Headache—Gemcitabine—lung cancer	0.000337	0.000347	CcSEcCtD
Ibandronate—Dyspepsia—Docetaxel—lung cancer	0.000336	0.000346	CcSEcCtD
Ibandronate—Haemorrhage—Doxorubicin—lung cancer	0.000335	0.000345	CcSEcCtD
Ibandronate—Pharyngitis—Doxorubicin—lung cancer	0.000333	0.000342	CcSEcCtD
Ibandronate—Decreased appetite—Docetaxel—lung cancer	0.000332	0.000341	CcSEcCtD
Ibandronate—Hypersensitivity—Paclitaxel—lung cancer	0.000332	0.000341	CcSEcCtD
Ibandronate—Urinary tract disorder—Doxorubicin—lung cancer	0.000331	0.000341	CcSEcCtD
Ibandronate—Oedema peripheral—Doxorubicin—lung cancer	0.00033	0.00034	CcSEcCtD
Ibandronate—Dysgeusia—Methotrexate—lung cancer	0.00033	0.00034	CcSEcCtD
Ibandronate—Gastrointestinal disorder—Docetaxel—lung cancer	0.00033	0.000339	CcSEcCtD
Ibandronate—Asthenia—Etoposide—lung cancer	0.000329	0.000339	CcSEcCtD
Ibandronate—Connective tissue disorder—Doxorubicin—lung cancer	0.000329	0.000339	CcSEcCtD
Ibandronate—Fatigue—Docetaxel—lung cancer	0.000329	0.000339	CcSEcCtD
Ibandronate—Urethral disorder—Doxorubicin—lung cancer	0.000329	0.000338	CcSEcCtD
Ibandronate—Nausea—Irinotecan—lung cancer	0.000328	0.000337	CcSEcCtD
Ibandronate—Constipation—Docetaxel—lung cancer	0.000326	0.000336	CcSEcCtD
Ibandronate—Pain—Docetaxel—lung cancer	0.000326	0.000336	CcSEcCtD
Ibandronate—Back pain—Methotrexate—lung cancer	0.000326	0.000335	CcSEcCtD
Ibandronate—Pruritus—Etoposide—lung cancer	0.000325	0.000334	CcSEcCtD
Ibandronate—Asthenia—Paclitaxel—lung cancer	0.000323	0.000332	CcSEcCtD
Ibandronate—Nausea—Gemcitabine—lung cancer	0.000319	0.000329	CcSEcCtD
Ibandronate—Vomiting—Cisplatin—lung cancer	0.000319	0.000328	CcSEcCtD
Ibandronate—Pruritus—Paclitaxel—lung cancer	0.000319	0.000328	CcSEcCtD
Ibandronate—Rash—Cisplatin—lung cancer	0.000316	0.000325	CcSEcCtD
Ibandronate—Dermatitis—Cisplatin—lung cancer	0.000316	0.000325	CcSEcCtD
Ibandronate—Feeling abnormal—Docetaxel—lung cancer	0.000315	0.000324	CcSEcCtD
Ibandronate—Diarrhoea—Etoposide—lung cancer	0.000314	0.000323	CcSEcCtD
Ibandronate—Eye disorder—Doxorubicin—lung cancer	0.000313	0.000322	CcSEcCtD
Ibandronate—Ill-defined disorder—Methotrexate—lung cancer	0.000313	0.000322	CcSEcCtD
Ibandronate—Gastrointestinal pain—Docetaxel—lung cancer	0.000312	0.000321	CcSEcCtD
Ibandronate—Anaemia—Methotrexate—lung cancer	0.000312	0.000321	CcSEcCtD
Ibandronate—Cardiac disorder—Doxorubicin—lung cancer	0.000311	0.00032	CcSEcCtD
Ibandronate—Diarrhoea—Paclitaxel—lung cancer	0.000308	0.000317	CcSEcCtD
Ibandronate—Angiopathy—Doxorubicin—lung cancer	0.000304	0.000313	CcSEcCtD
Ibandronate—Malaise—Methotrexate—lung cancer	0.000304	0.000313	CcSEcCtD
Ibandronate—Dizziness—Etoposide—lung cancer	0.000304	0.000312	CcSEcCtD
Ibandronate—Immune system disorder—Doxorubicin—lung cancer	0.000303	0.000312	CcSEcCtD
Ibandronate—Vertigo—Methotrexate—lung cancer	0.000303	0.000312	CcSEcCtD
Ibandronate—Mediastinal disorder—Doxorubicin—lung cancer	0.000302	0.000311	CcSEcCtD
Ibandronate—Abdominal pain—Docetaxel—lung cancer	0.000302	0.00031	CcSEcCtD
Ibandronate—Body temperature increased—Docetaxel—lung cancer	0.000302	0.00031	CcSEcCtD
Ibandronate—Chills—Doxorubicin—lung cancer	0.000301	0.00031	CcSEcCtD
Ibandronate—Dizziness—Paclitaxel—lung cancer	0.000298	0.000306	CcSEcCtD
Ibandronate—Nausea—Cisplatin—lung cancer	0.000298	0.000306	CcSEcCtD
Ibandronate—Alopecia—Doxorubicin—lung cancer	0.000296	0.000305	CcSEcCtD
Ibandronate—Mental disorder—Doxorubicin—lung cancer	0.000294	0.000302	CcSEcCtD
Ibandronate—Vomiting—Etoposide—lung cancer	0.000292	0.0003	CcSEcCtD
Ibandronate—Malnutrition—Doxorubicin—lung cancer	0.000292	0.0003	CcSEcCtD
Ibandronate—Erythema—Doxorubicin—lung cancer	0.000292	0.0003	CcSEcCtD
Ibandronate—Rash—Etoposide—lung cancer	0.00029	0.000298	CcSEcCtD
Ibandronate—Dermatitis—Etoposide—lung cancer	0.000289	0.000298	CcSEcCtD
Ibandronate—Headache—Etoposide—lung cancer	0.000288	0.000296	CcSEcCtD
Ibandronate—Flatulence—Doxorubicin—lung cancer	0.000288	0.000296	CcSEcCtD
Ibandronate—Chest pain—Methotrexate—lung cancer	0.000287	0.000295	CcSEcCtD
Ibandronate—Arthralgia—Methotrexate—lung cancer	0.000287	0.000295	CcSEcCtD
Ibandronate—Myalgia—Methotrexate—lung cancer	0.000287	0.000295	CcSEcCtD
Ibandronate—Vomiting—Paclitaxel—lung cancer	0.000286	0.000295	CcSEcCtD
Ibandronate—Dysgeusia—Doxorubicin—lung cancer	0.000286	0.000294	CcSEcCtD
Ibandronate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	0.000285	0.000293	CcSEcCtD
Ibandronate—Rash—Paclitaxel—lung cancer	0.000284	0.000292	CcSEcCtD
Ibandronate—Dermatitis—Paclitaxel—lung cancer	0.000284	0.000292	CcSEcCtD
Ibandronate—Discomfort—Methotrexate—lung cancer	0.000284	0.000292	CcSEcCtD
Ibandronate—Back pain—Doxorubicin—lung cancer	0.000282	0.00029	CcSEcCtD
Ibandronate—Headache—Paclitaxel—lung cancer	0.000282	0.00029	CcSEcCtD
Ibandronate—Hypersensitivity—Docetaxel—lung cancer	0.000281	0.000289	CcSEcCtD
Ibandronate—Muscle spasms—Doxorubicin—lung cancer	0.000281	0.000289	CcSEcCtD
Ibandronate—Anaphylactic shock—Methotrexate—lung cancer	0.000275	0.000283	CcSEcCtD
Ibandronate—Asthenia—Docetaxel—lung cancer	0.000274	0.000282	CcSEcCtD
Ibandronate—Infection—Methotrexate—lung cancer	0.000273	0.000281	CcSEcCtD
Ibandronate—Nausea—Etoposide—lung cancer	0.000273	0.000281	CcSEcCtD
Ibandronate—Ill-defined disorder—Doxorubicin—lung cancer	0.000271	0.000279	CcSEcCtD
Ibandronate—Pruritus—Docetaxel—lung cancer	0.00027	0.000278	CcSEcCtD
Ibandronate—Nervous system disorder—Methotrexate—lung cancer	0.00027	0.000278	CcSEcCtD
Ibandronate—Anaemia—Doxorubicin—lung cancer	0.00027	0.000278	CcSEcCtD
Ibandronate—Nausea—Paclitaxel—lung cancer	0.000267	0.000275	CcSEcCtD
Ibandronate—Skin disorder—Methotrexate—lung cancer	0.000267	0.000275	CcSEcCtD
Ibandronate—Hyperhidrosis—Methotrexate—lung cancer	0.000266	0.000274	CcSEcCtD
Ibandronate—Malaise—Doxorubicin—lung cancer	0.000263	0.000271	CcSEcCtD
Ibandronate—Vertigo—Doxorubicin—lung cancer	0.000262	0.00027	CcSEcCtD
Ibandronate—Diarrhoea—Docetaxel—lung cancer	0.000261	0.000269	CcSEcCtD
Ibandronate—Palpitations—Doxorubicin—lung cancer	0.000258	0.000265	CcSEcCtD
Ibandronate—Dizziness—Docetaxel—lung cancer	0.000252	0.00026	CcSEcCtD
Ibandronate—Hypertension—Doxorubicin—lung cancer	0.000252	0.000259	CcSEcCtD
Ibandronate—Musculoskeletal discomfort—Methotrexate—lung cancer	0.000251	0.000258	CcSEcCtD
Ibandronate—Insomnia—Methotrexate—lung cancer	0.000249	0.000256	CcSEcCtD
Ibandronate—Arthralgia—Doxorubicin—lung cancer	0.000248	0.000256	CcSEcCtD
Ibandronate—Myalgia—Doxorubicin—lung cancer	0.000248	0.000256	CcSEcCtD
Ibandronate—Chest pain—Doxorubicin—lung cancer	0.000248	0.000256	CcSEcCtD
Ibandronate—Anxiety—Doxorubicin—lung cancer	0.000248	0.000255	CcSEcCtD
Ibandronate—Paraesthesia—Methotrexate—lung cancer	0.000247	0.000254	CcSEcCtD
Ibandronate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	0.000247	0.000254	CcSEcCtD
Ibandronate—Discomfort—Doxorubicin—lung cancer	0.000245	0.000253	CcSEcCtD
Ibandronate—Dry mouth—Doxorubicin—lung cancer	0.000243	0.00025	CcSEcCtD
Ibandronate—Vomiting—Docetaxel—lung cancer	0.000243	0.00025	CcSEcCtD
Ibandronate—Dyspepsia—Methotrexate—lung cancer	0.000242	0.000249	CcSEcCtD
Ibandronate—Rash—Docetaxel—lung cancer	0.000241	0.000248	CcSEcCtD
Ibandronate—Dermatitis—Docetaxel—lung cancer	0.00024	0.000247	CcSEcCtD
Ibandronate—Decreased appetite—Methotrexate—lung cancer	0.000239	0.000246	CcSEcCtD
Ibandronate—Headache—Docetaxel—lung cancer	0.000239	0.000246	CcSEcCtD
Ibandronate—Anaphylactic shock—Doxorubicin—lung cancer	0.000238	0.000245	CcSEcCtD
Ibandronate—Gastrointestinal disorder—Methotrexate—lung cancer	0.000237	0.000244	CcSEcCtD
Ibandronate—Fatigue—Methotrexate—lung cancer	0.000237	0.000244	CcSEcCtD
Ibandronate—Infection—Doxorubicin—lung cancer	0.000237	0.000243	CcSEcCtD
Ibandronate—Pain—Methotrexate—lung cancer	0.000235	0.000242	CcSEcCtD
Ibandronate—Shock—Doxorubicin—lung cancer	0.000234	0.000241	CcSEcCtD
Ibandronate—Nervous system disorder—Doxorubicin—lung cancer	0.000234	0.00024	CcSEcCtD
Ibandronate—Skin disorder—Doxorubicin—lung cancer	0.000231	0.000238	CcSEcCtD
Ibandronate—Hyperhidrosis—Doxorubicin—lung cancer	0.00023	0.000237	CcSEcCtD
Ibandronate—Nausea—Docetaxel—lung cancer	0.000227	0.000233	CcSEcCtD
Ibandronate—Feeling abnormal—Methotrexate—lung cancer	0.000227	0.000233	CcSEcCtD
Ibandronate—Gastrointestinal pain—Methotrexate—lung cancer	0.000225	0.000231	CcSEcCtD
Ibandronate—Urticaria—Methotrexate—lung cancer	0.000219	0.000225	CcSEcCtD
Ibandronate—Abdominal pain—Methotrexate—lung cancer	0.000217	0.000224	CcSEcCtD
Ibandronate—Body temperature increased—Methotrexate—lung cancer	0.000217	0.000224	CcSEcCtD
Ibandronate—Musculoskeletal discomfort—Doxorubicin—lung cancer	0.000217	0.000223	CcSEcCtD
Ibandronate—Insomnia—Doxorubicin—lung cancer	0.000215	0.000222	CcSEcCtD
Ibandronate—Paraesthesia—Doxorubicin—lung cancer	0.000214	0.00022	CcSEcCtD
Ibandronate—Dyspepsia—Doxorubicin—lung cancer	0.00021	0.000216	CcSEcCtD
Ibandronate—Decreased appetite—Doxorubicin—lung cancer	0.000207	0.000213	CcSEcCtD
Ibandronate—Gastrointestinal disorder—Doxorubicin—lung cancer	0.000206	0.000212	CcSEcCtD
Ibandronate—Fatigue—Doxorubicin—lung cancer	0.000205	0.000211	CcSEcCtD
Ibandronate—Pain—Doxorubicin—lung cancer	0.000204	0.00021	CcSEcCtD
Ibandronate—Constipation—Doxorubicin—lung cancer	0.000204	0.00021	CcSEcCtD
Ibandronate—Hypersensitivity—Methotrexate—lung cancer	0.000203	0.000209	CcSEcCtD
Ibandronate—Asthenia—Methotrexate—lung cancer	0.000197	0.000203	CcSEcCtD
Ibandronate—Feeling abnormal—Doxorubicin—lung cancer	0.000196	0.000202	CcSEcCtD
Ibandronate—Gastrointestinal pain—Doxorubicin—lung cancer	0.000195	0.0002	CcSEcCtD
Ibandronate—Pruritus—Methotrexate—lung cancer	0.000195	0.0002	CcSEcCtD
Ibandronate—Urticaria—Doxorubicin—lung cancer	0.000189	0.000195	CcSEcCtD
Ibandronate—Abdominal pain—Doxorubicin—lung cancer	0.000188	0.000194	CcSEcCtD
Ibandronate—Body temperature increased—Doxorubicin—lung cancer	0.000188	0.000194	CcSEcCtD
Ibandronate—Diarrhoea—Methotrexate—lung cancer	0.000188	0.000194	CcSEcCtD
Ibandronate—Dizziness—Methotrexate—lung cancer	0.000182	0.000187	CcSEcCtD
Ibandronate—Hypersensitivity—Doxorubicin—lung cancer	0.000175	0.000181	CcSEcCtD
Ibandronate—Vomiting—Methotrexate—lung cancer	0.000175	0.00018	CcSEcCtD
Ibandronate—Rash—Methotrexate—lung cancer	0.000173	0.000178	CcSEcCtD
Ibandronate—Dermatitis—Methotrexate—lung cancer	0.000173	0.000178	CcSEcCtD
Ibandronate—Headache—Methotrexate—lung cancer	0.000172	0.000177	CcSEcCtD
Ibandronate—Asthenia—Doxorubicin—lung cancer	0.000171	0.000176	CcSEcCtD
Ibandronate—Pruritus—Doxorubicin—lung cancer	0.000169	0.000173	CcSEcCtD
Ibandronate—Nausea—Methotrexate—lung cancer	0.000163	0.000168	CcSEcCtD
Ibandronate—Diarrhoea—Doxorubicin—lung cancer	0.000163	0.000168	CcSEcCtD
Ibandronate—Dizziness—Doxorubicin—lung cancer	0.000158	0.000162	CcSEcCtD
Ibandronate—Vomiting—Doxorubicin—lung cancer	0.000151	0.000156	CcSEcCtD
Ibandronate—Rash—Doxorubicin—lung cancer	0.00015	0.000155	CcSEcCtD
Ibandronate—Dermatitis—Doxorubicin—lung cancer	0.00015	0.000154	CcSEcCtD
Ibandronate—Headache—Doxorubicin—lung cancer	0.000149	0.000154	CcSEcCtD
Ibandronate—Nausea—Doxorubicin—lung cancer	0.000141	0.000146	CcSEcCtD
